Positive effect of restrictions on antibiotic consumption

Objective & Hypothesis:Background/aim: This study aimed to examine the change in the etiology of hospital infections with restricting and releasing of group2 carbapenems (G2C) (meropenem/imipenem/doripenem).Materials and methods: This study was planned in three periods.

📊

Key Findings & Data:Study period 1 (SP-1): Carbapenems were prescribed withoutrestriction by infectious disease specialists.

💡

Conclusion & Impact:Positive behaviors that were obtained during the restricted period were continued with releaseof restriction.

🔬Design:Research Article

📍Scope:2085 Verileri

⚙️Variables:Domain Parameters

Abstract

Background/aim: This study aimed to examine the change in the etiology of hospital infections with restricting and releasing of group2 carbapenems (G2C) (meropenem/imipenem/doripenem).Materials and methods: This study was planned in three periods. Study period 1 (SP-1): Carbapenems were prescribed withoutrestriction by infectious disease specialists. SP-2: G2C prescription was restricted. SP-3: Carbapenem prescription was released.Results: In total, 4443 cases [1053 in SP-1 (23.7%), 1332 in SP-2 (29.9%), and 2085 in SP-3 (46.9%)] were included in the study. Infectionrates were 11%, 6.5%, and 7.9% in SP-1, SP-2, and SP-3, respectively (P = 0.001). Acinetobacter spp.-related hospital infection rates were3.9%, 1.2%, and 1.8%, in SP-1, SP-2, and SP-3, respectively (P = 0.0001). Infection related mortality in SP-1, SP-2, and SP-3 was 7.3%,5%, and 3.8%, respectively (P = 0.001).Conclusion: Hospital-acquired Acinetobacter infections, antibiotic consumption, and infection-related mortality were decreasedsignificantly with the restriction of G2C. Positive behaviors that were obtained during the restricted period were continued with releaseof restriction.

🔖

Cite This Article

GÜÇLÜ, E., KARABAY, O., KAYA, G., ÖĞÜTLÜ, A. (2022). Positive effect of restrictions on antibiotic consumption. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 2, 361–365. https://ajindex.com/articles/610396

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, Lim JE, Lee SK, Lee SH, Lee KJ et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010; 10: 2-11.
Aldeyab MA, Kearney MP, Scott MG, Aldiab MA, Alahmadi YM, Darwish Elhajji FW, Magee FA, McElnay JC. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemoth 2012; 67: 2988-2996.
Lima AL, Oliveira PR, Paula AP, Dal-Paz K, Almeida JN Jr, Félix Cda S, Rossi F. Carbapenem stewardship – positive impact on hospital ecology. Braz J Infect Dis 2011; 15: 1-5.
Mozes J, Ebrahimi F, Goracz O, Miszti C, Kardos G. Effect of carbapenem consumption patterns on the molecular epidemiology and carbapenem resistance of Acinetobacter baumannii. J Med Microbiol 2014; 63: 1654-1662.
Chen CY, Tien FM, Sheng WH, Huang SY, Yao M, Tang JL, Tsay W, Tien HF, Hsueh PR. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013. Int J Antimicrob Ag 2017; 49: 272-281.
Beriş FŞ, Budak EE, Gülek D, Uzun A, Çizmeci Z, Mengeloğlu FZ, Direkel Ş, Çetinkol Y, Ay Altıntop Y, Iraz M et al. Investigation of the frequency and distribution of beta-lactamase genes in the clinical isolates of Acinetobacter baumannii collected from different regions of Turkey: a multicenter study. Mikrobiyol Bul 2016; 50: 511-521.
Nemli SA, Demirdal T. Acinetobacter baumannii Suşlarında Antibiyotik Direncindeki Değişimin Değerlendirilmesi. 6. Türkiye EKMUD bilimsel platformu poster sunumları; 4–8 Nisan 2017;
Antalya, Türkiye. Mediterranean Journal of Infection, Microbes and Antimicrobials 2017; 6: 45-169. Ministry of Health of Turkey Republic. Hospital Infections Report (UHESA). Website http://hizmetstandartlari.saglik.gov. tr/Eklenti/2815,2014-ulusal-ozet-rapor-1pdf.pdf?0 [accessed 27 January 2017].
Guclu E, Ogutlu A, Karabay O, Demirdal T, Erayman I, Hosoglu S, Turhan V, Erol S, Oztoprak N, Batirel A et al. Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study. J Chemotherapy 2016; 9478: 1-6.
Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patie